A large multicentre study in patients with rheumatic diseases confirmed these findings, since anti-TNF therapies were associated with decreased odds of hospitalisation for COVID-19, while neither the exposure to conventional disease-modifying antirheumatic drugs nor non-steroidal anti-inflammatory drugs were associated with increased odds of hospitalisation [33]. The gene discussed is TNF; the disease is rheumatic disorder.